Is hepatic transplantation justified for primary liver cancer?
β Scribed by Robert A. Fisher; Daniel G. Maluf; Luke Wolfe; Bridgette Williams; Adrian Cotterell; R. Todd Stravitz; Douglas Heuman; Marc Posner
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 212 KB
- Volume
- 95
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A concise, yet objective overview of Hepatocellular Carcinoma (HCC) treatment in 2006 with an intent to transplant is presented. The most significant variables impacting on the use of hepatic transplantation as therapy for primary liver cancer are developed under the headings of: Staging Criteria; Organ allocation; Transplant dropout minimization therapies; and Effects on the HCC general population. The pertinent medical literature and update of an ongoing intentβtoβtreat HCC with transplant single center randomized control trial are reviewed. J. Surg. Oncol. 2007;95:674β679. Β© 2007 WileyβLiss, Inc.
π SIMILAR VOLUMES
A 57-year-old gentleman with a past medical history significant for Hodgkin's lymphoma in 1977 (which required splenectomy, radiation therapy, and chemotherapy) was incidentally found to have a large left lobe liver mass in July 2008 while he was undergoing computed tomography imaging for presumed n
Cirrhotic patients with hereditary hemochromatosis (HHC) have an increased risk of primary liver cancer (PLC). The purpose of this study was to determine the prevalence of primary liver cancer in patients with HHC undergoing orthotopic liver transplantation (OLT). Five liver transplant centers were
Two patients undergoing liver transplantation for classical end-stage primary biliary cirrhosis (PBC) are described, who went on to develop de novo autoimmune hepatitis (AIH) in the transplanted liver. The presentation, in both instances, was with malaise and lethargy. Markedly elevated serum transa